Edited By: Karl-Anton Kreuzer
Online ISSN:1600-0609|
Print ISSN:0902-4441|
© John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
The European Journal of Haematology is an international haematology journal for communication of basic and clinical research in haematology and related areas of thrombosis, haemostasis and haemophilia. We welcome manuscripts on molecular, cellular and clinical research on diseases of the blood, vascular and lymphatic tissue, and on basic molecular and cellular research related to normal development and function of the blood, vascular and lymphatic tissue. We provide a simplified submission process that works collaboratively across haematology so every submitted paper has a home.
Journal Metrics
- 4.6CiteScore
- 2.3Journal Impact Factor
- 21%Acceptance rate
- 3 days Submission to first decision
On the Cover
Skip slideshow
more >
The cover image is based on the Article Plasma monomeric ApoA1 and high-density lipoprotein bound ApoA1 are markedly decreased and associated with low levels of lipophilic antioxidants in sickle cell disease: A potential new pathway for therapy by Eric J. Niesor et al., https://doi.org/10.1111/ejh.14288
The cover image is based on the Review The current challenges faced by people with hemophilia B by Wolfgang Miesbach et al., https://doi.org/10.1111/ejh.14135
The cover image is based on the Original Article PD-L1 expression predicts efficacy in the phase II SPiReL trial with MVP-S, pembrolizumab, and low-dose CPA in R/R DLBCL by Irina Amitai et al., https://doi.org/10.1111/ejh.13982
Articles
ORIGINAL ARTICLE
Eltrombopag for Bone Marrow Failure in Fanconi Anemia: Results From the Phase II Clinical Trial FANCREV
June Iriondo, Josune Zubicaray, Paula Río, Albert Català, María Solsona, Alejandro Sanz, Ana Gómez, Elena Sebastián, Ana de la Cruz, Almudena Galán, Susana Navarro, Lise Larcher, Nagore García de Andoin, Jose Javier Uriz, José Manuel Vagace, Jesús Gonzalez de Pablo, Maria Roser Pujol, Eileen Nicoletti, Jordi Surrallés, Silvia Martín-Prado, Jonathan D. Schwartz, Jean Soulier, Juan Antonio Bueren, Julián Sevilla,
- 16 July 2025
ORIGINAL ARTICLE
Open access
Patients With Relapsed Large B‐Cell Lymphoma After 12 Months Have a Similarly Poor Prognosis to Those Relapsing Within 12 Months
Hilde T. van der Galiën, Hilde A. M. Kooistra, Robby Kibbelaar, Nic J. G. M. Veeger, Marcel Nijland, Gerwin Huls, Tom van Meerten, Rozemarijn S. van Rijn, The Hemobase Population Registry Consortium,
- 9 July 2025
ORIGINAL ARTICLE
Open access
Final Results From a Large, Non‐Interventional, Phase 4 Study of Ruxolitinib for the Treatment of Myelofibrosis in Clinical Routine
Steffen Koschmieder, Susanne Isfort, Clemens Schulte, Lutz Jacobasch, Thomas Geer, Marcel Reiser, Michael Koenigsmann, Bernhard Heinrich, Jürgen Wehmeyer, Eyck von der Heyde, Hans Tesch, Benedikt Gröschl, Petra Bachhuber, Susanne Großer, Michael Koehler, Heike L. Pahl,
- 6 July 2025
REVIEW
free access
Construction of Lymphoma Organoids and Applications in Tumor Microenvironment Research
- 30 June 2025
The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef.
free access
The many roles of tranexamic acid: An overview of the clinical indications for TXA in medical and surgical patients
Johnny Cai, Jessica Ribkoff, Sven Olson, Vikram Raghunathan, Hanny Al-Samkari, Thomas G. DeLoughery, Joseph J. Shatzel,
- 79-87
- 14 November 2019
free access
The vaso‐occlusive pain crisis in sickle cell disease: Definition, pathophysiology, and management
- 237-246
- 16 April 2020
free access
The role of iron repletion in adult iron deficiency anemia and other diseases
Benjamin Elstrott, Lubna Khan, Sven Olson, Vikram Raghunathan, Thomas DeLoughery, Joseph J. Shatzel,
- 153-161
- 12 November 2019
